Literature DB >> 15993356

A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes.

Stuart A Chalew1, Robert J McCarter, Jacinta Thomas, Jessica L Thomson, James M Hempe.   

Abstract

PROBLEM: The Glycosylation Gap (GGAP) based on fructosamine (F) measurement and the Hemoglobin Glycation Index (HGI) based on mean blood glucose (MBG) are two indices of between-individual differences in glycated hemoglobin (HbA1c) adjusted for glycemia. We sought to simultaneously compare GGAP with HGI and other estimates of glycemia.
METHODS: HbA1c, F, and MBG level were obtained at a clinic visit from 62 patients with Type 1 diabetes. GGAP and HGI were calculated from the data as previously described. The variables were compared by correlation analysis. The concordance of patient classification by GGAP and HGI was compared by weighted kappa test.
RESULTS: The mean HbA1c=11.1+/-2.7%, F=372.0+/-136.6 mol/l, MBG=186.5+/-58.4 mg/dl, HGI=0.0+/-2.0, and GGAP=0.0+/-1.9. MBG, HbA1c, and F were all highly correlated with each other. The HGI and GGAP were highly correlated (r=.73, P<.0001) and similar in both magnitude and direction. There was good agreement between HGI and GGAP classifications of patients into high, moderate, and low glycation groups (P<.0075).
CONCLUSIONS: GGAP and MBG give similar information regarding between-patient differences in HbA1c among patients with diabetes. Thus, biological variation in HbA1c is not an artifact of variability in glucose measurements comprising the MBG. Individual patient factors influence the intracellular glycation of HbA1c in addition to the effect of extracellular glycemia, which is manifested as a between-individual biological variation in HbA1c.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993356     DOI: 10.1016/j.jdiacomp.2005.01.004

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  11 in total

1.  Evaluation of glycated albumin and microalbuminuria as early risk markers of nephropathy in type 2 diabetes mellitus.

Authors:  Suresh Babu Kondaveeti; Kumaraswamy D; Shishir Mishra; Aravind Kumar R; I Anand Shaker
Journal:  J Clin Diagn Res       Date:  2013-07-01

2.  Racial disparity in HbA1c persists when fructosamine is used as a surrogate for mean blood glucose in youth with type 1 diabetes.

Authors:  Stuart Chalew; Mahmoud Hamdan
Journal:  Pediatr Diabetes       Date:  2018-08-21       Impact factor: 4.866

3.  Association between Inflammation and Biological Variation in Hemoglobin A1c in U.S. Nondiabetic Adults.

Authors:  Shuqian Liu; James M Hempe; Robert J McCarter; Shengxu Li; Vivian A Fonseca
Journal:  J Clin Endocrinol Metab       Date:  2015-04-13       Impact factor: 5.958

4.  The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial.

Authors:  James M Hempe; Shuqian Liu; Leann Myers; Robert J McCarter; John B Buse; Vivian Fonseca
Journal:  Diabetes Care       Date:  2015-04-17       Impact factor: 19.112

5.  Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation.

Authors:  Paramjit K Khera; Clinton H Joiner; Anthony Carruthers; Christopher J Lindsell; Eric P Smith; Robert S Franco; Yancey R Holmes; Robert M Cohen
Journal:  Diabetes       Date:  2008-06-30       Impact factor: 9.461

6.  Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring.

Authors:  Mary E Larkin; David M Nathan; Ionut Bebu; Heidi Krause-Steinrauf; William H Herman; John M Higgins; Margaret Tiktin; Robert M Cohen; Claire Lund; Richard M Bergenstal; Mary L Johnson; Valerie Arends
Journal:  Diabetes Technol Ther       Date:  2019-09-04       Impact factor: 6.118

7.  Association of glycation gap with mortality and vascular complications in diabetes.

Authors:  Ananth U Nayak; Alan M Nevill; Paul Bassett; Baldev M Singh
Journal:  Diabetes Care       Date:  2013-07-08       Impact factor: 19.112

8.  Evidence for consistency of the glycation gap in diabetes.

Authors:  Ananth U Nayak; Martin R Holland; David R Macdonald; Alan Nevill; Baldev M Singh
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

Review 9.  Update on biomarkers of glycemic control.

Authors:  Maja Krhač; Marijana Vučić Lovrenčić
Journal:  World J Diabetes       Date:  2019-01-15

10.  Variables involved in the discordance between HbA1c and fructosamine: the glycation gap revisited.

Authors:  Carles Zafon; Andreea Ciudin; Silvia Valladares; Jordi Mesa; Rafael Simó
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.